One of the biggest risk factors for developing liver cancer is a high-fat diet. A new study from MIT reveals how a fatty diet rewires liver cells and makes them more prone to becoming cancerous. The ...

Besides convenience, one of the main benefits of self-driving cars is supposed to be safety. Yet in a bizarre move, Waymo — whose self-driving cabs had been enjoying extraordinary safety metrics — has ...

GLP-1 is the naturally produced hormone whose function is being mimicked by drugs like semaglutide and tirzepatide, the active ingredients in popular and highly effective weight-loss drugs like Wegovy ...

Pregnancy and breastfeeding leave behind long-lived CD8+ T lymphocytes that provide lasting immune protection in breast tissue, according to new research, a discovery that could reshape understanding ...

The cost of sequencing DNA has dropped dramatically, and with technologies like CRISPR, gene editing is becoming more precise and powerful than ever. From curing genetic diseases to designing the next ...

Tucked among the many pages of President Trump’s signature tax cuts is a single paragraph that provisions money for the Department of Homeland Security. Totaling $10 billion, and created to help ...

The aim of immunotherapy strategies is to leverage cells in the patient's own immune system to destroy tumor cells. Using a preclinical model, scientists from the Institut Pasteur and Inserm ...

Cancer cells can brainwash their neighbors. Like the CIA deploying secret agents to turn an enemy, tumors use a similar strategy to manipulate nearby cells. The tumors’ agents are mitochondria, the ...

A first-in-class antisense oligonucleotide — RES-010 (Resalis Therapeutics, Turin, Italy) — may complement and enhance the efficacy of antiobesity drugs such as GLP-1 receptor agonists (RAs), ...

Indiana University School of Medicine scientists have developed a new method that shifts the behavior of immunosuppressive cells in tumors, turning them from cancer protectors into tumor fighters. The ...

Baohua Zhou, Naresh Singh and Samantha Sharma study immune cells that could be reprogrammed to fight cancer in the lab. INDIANAPOLIS — Indiana University School of Medicine scientists have developed a ...